CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. (SHE:000908)
China
· Delayed Price · Currency is CNY 7.37
-0.09 (-1.21%)
Apr 29, 2026, 3:04 PM CST
SHE:000908 Revenue
CSPC Hunan Jingfeng Pharmaceutical had revenue of 107.54M CNY in the quarter ending March 31, 2026, with 7.42% growth. This brings the company's revenue in the last twelve months to 385.54M, down -7.22% year-over-year. In the year 2025, CSPC Hunan Jingfeng Pharmaceutical had annual revenue of 378.11M, down -9.11%.
Revenue (ttm)
385.54M
Revenue Growth
-7.22%
P/S Ratio
34.05
Revenue / Employee
704.83K
Employees
547
Market Cap
13.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 378.11M | -37.92M | -9.11% |
| Dec 31, 2024 | 416.03M | -240.86M | -36.67% |
| Dec 31, 2023 | 656.89M | -183.76M | -21.86% |
| Jan 1, 2023 | 840.66M | 29.47M | 3.63% |
| Jan 1, 2022 | 811.18M | -66.74M | -7.60% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Wolwo Bio-Pharmaceutical | 1.09B |
| Aurora Optoelectronics | 465.12M |
| Yifan Pharmaceutical | 5.06B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 3.11B |
| Shanghai InnoStar Bio-tech | 811.33M |
| GuangYuYuan Chinese Herbal Medicine | 1.44B |
| Nanjing Pharmaceutical Group Company | 54.96B |
| Chongqing Lummy Pharmaceutical | 759.50M |